Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by rummageron Mar 08, 2021 8:58am
262 Views
Post# 32741765

RE:RE:RE:RE:RE:RE:RE:JAMA Cardiology Study

RE:RE:RE:RE:RE:RE:RE:JAMA Cardiology StudyNo matter how big or successful, every company has negatives which may or may not be serious enough to affect stock price. I don't understand why people want to close their minds to ALL of the information available to investors by ignoring information they don't like. 

Some advice from an experienced investor (not me!!!!):

https://www.pinnacledigest.com/tsx-venture-investing/why-investors-lose-money-buying-tsx-venture-stocks/

Note Number 7 "Rule"


#7 – Don’t take profits when they’re there:

It’s amazing to see someone make 100% on their investment in a Venture stock over a few months and not take even a portion of their money off the table. Greed. Retail investors often get caught up in the bliss and forget why they first took a risk. Don’t be a sucker. Parabolic stock rises on the Venture typically lose 30-50% from the peak within six months.

<< Previous
Bullboard Posts
Next >>